Vivek Ramaswamy is a candidate in the 2024 Republican Party presidential primaries. He is an American entrepreneur who was born in Cincinnati to Indian immigrant parents. He declared his candidacy for the Republican Party’s nomination for president in the 2024 election. His net worth is estimated to be at $630 million; his wealth comes from biotech and financial businesses.
Vivek Ramaswamy Bio, Early Life and Religion
Vivek Ramaswamy was born to Hindu Tamil Brahmin immigrant parents on August 9, 1985, in Cincinnati, Ohio, USA. He comes from an Ohio family. His ancestors hailed from Kerala. Both of his parents have advanced degrees; his father, V. Ganapathy Ramaswamy, is an engineer and patent attorney for General Electric, while his mother, Geetha Ramaswamy.
She is a geriatric psychiatrist who earned her degree from Mysore Medical College & Research Institute. His parents left their ancestral home in a traditional agraharam in the town of Vadakkencherry in the Palakkad district of Kerala to start a new life in the United States.
Vivek Ramaswamy Height and Weight
Vivek Ramaswamy height is 5 feet 7 inches tall and body weight is 71 Kg or 156 lbs. He has dark brown eyes and has blonde hair.
Vivek Ramaswamy Wiki
Real Name | Vivek Ramaswamy |
Age | 38 years old (As of 2023) |
Birthdate | August 9, 1985 |
Ethnicity | Mixed |
Height | 5 feet 7 inches |
Weight | 71 Kg |
Wife | Apoorva Ramaswamy |
Net Worth | $630 million |
Vivek Ramaswamy Wife
Vivek Ramaswamy is married with Apoorva Ramaswamy who is a physician. He was a legal student at Yale, while she was a medical student and they ended up meeting. Couple has two sons together. She is of Hindu religion.
Ramaswamy’s campaign advisor said his net worth was more than $1 billion, in 2023. As of 2016, he lived in New York City. He owned a house in Butler County, Ohio, in 2021.
What Is The Net Worth Of Vivek Ramaswamy?
Vivek Ramaswamy co-founded Chapter Medicare, a Medicare navigation platform, in 2020. He remains the sixth-largest shareholder of Roivant. He called himself a “scientist” and said, “I developed a number of medicines”, in 2023. In 2021, he stepped down as CEO of Roivant, but remained its chairman until 2023.